New provisions cover products with no intended medical purpose
The US FDA has announced that manufacturers of new COVID-19 tests should now follow traditional premarket pathways.
The UK’s MHRA invited public comment regarding its proposed fee increases.
The US FDA announced that it has launched a pilot program designed to help medical device premarket reviews become more efficient.
The US FDA released a list of guidances it plans to issue over its 2023 fiscal year.
New European MDCG paper lays out actions to increase Notified Body capacity, avoid medical device and IVD shortages
The US FDA has issued draft guidance on select updates for the Breakthrough Devices Program guidance, expanding its scope to devices that will improve accessibility.
A survey from the European Commission shows that many medical device and in vitro diagnostic (IVD) manufacturers have yet to apply for certification under the Medical Devices Regulation (MDR) or In Vitro Diagnostic Medical Devices Regulation (IVDR).
The FDA released its 2023 medical device user fees and some have increased sharply since last year.
Health Canada reminded manufacturers of EHR-based medical devices to obtain a medical device license and/or establishment license.